Neoadjuvant hormone therapy before radical prostatectomy does not improve disease-specific survival.
Steiner
M S
MS
Department of Urology, University of Tennessee, Memphis, 956 Court Avenue, Room H216, Memphis, TN 38163, USA. Msteiner@utmem.edu
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D006801:Humans; D016729:Leuprolide / Q000627:therapeutic use*; D008297:Male; D011300:Preoperative Care; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality* / Q000601:surgery; D015996:Survival Rate
D018931:Antineoplastic Agents, Hormonal; D016729:Leuprolide